LULU vs TMO: Which Is the Better Buy?
Side-by-side comparison of Lululemon Athletica Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-17.
Lululemon Athletica Inc. · Consumer Cyclical
$116.33
+45.0% upside to fair value
Med Conviction
Grade B-
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
LULU has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
LULU |
TMO |
| Current Price |
$116.33 |
$464.61 |
| Fair Value Estimate |
$168.68 |
$498.27 |
| Upside to Fair Value |
+45.0%
|
+7.2%
|
| Market Cap |
$13.2B |
$172.7B |
| Forward P/E |
—
|
25.2x
|
| EV / EBITDA |
5.3x
|
19.1x
|
| Price / Sales |
1.2x
|
3.8x
|
| Price / FCF |
10.3x
|
25.6x
|
| Revenue Growth YoY |
+4.3%
|
+6.2%
|
| Gross Margin |
55.7%
|
39.4%
|
| Operating Margin |
18.2%
|
17.8%
|
| Return on Equity |
31.3%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
9.69%
|
3.91%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Lululemon Athletica is a premium athletic-apparel retailer whose technical-product innovation, powerful brand, direct-to-consumer retail and e-commerce model, and community-led marketing have historically supported high returns, including a 31.3% ROE, 55.7% gross margin, 18.2% operating margin, and 13.0% net margin. The investment case is now a turnaround rather than a clean compounding story: in…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
LULU |
TMO |
| Zone Low |
$126.51 |
$373.70 |
| Zone High |
$143.38 |
$423.53 |
| In Buy Zone? |
Yes
|
No
|